Results 11 to 20 of about 1,772,527 (156)
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML [PDF]
In acute myeloid leukemia, hypomethylating agents decitabine and azacytidine are used interchangeably. Here, the authors show that the major metabolite of decitabine, but not azacytidine, is subject to SAMHD1 inactivation, highlighting SAMHD1 as a ...
Thomas Oellerich +23 more
doaj +9 more sources
Retroelements in the human genome are silenced via multiple mechanisms, including DNA methylation, to prevent their potential mutagenic effect. Retroelement activity, demonstrated by their expression and somatic retrotransposition events, was shown to be
Šárka Pavlová +14 more
doaj +2 more sources
Background and Clinical Significance: Intermediate- to high-risk Myelodysplastic Syndrome (MDS), according to the Revised International Prognostic Scoring System (IPSS-M), confers a high risk of progression into acute myeloid leukemia.
Sofia Brites Alves +1 more
doaj +2 more sources
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS [PDF]
In 2002, the WHO classification reduced the proportion of blasts in the bone marrow (BM) necessary for the diagnosis of acute myeloid leukemia (AML) from 30% to 20%, eliminating the RAEB-t subtype of myelodysplastic syndromes (MDS).
Eleonora De Bellis +11 more
doaj +2 more sources
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries [PDF]
The outcome of acute myeloid leukemia patients aged 70 years or older is poor. Defining the best treatment option remains controversial especially when choosing between intensive chemotherapy and hypomethylating agents.
Dumas, Pierre-Yves +49 more
core +1 more source
Supplemental Material, sj-pdf-1-ccx-10.1177_10732748221074051 for Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents by Sridhar A Malkaram, Aymen Shatnawi, Jun Fan, Hetty Carraway, James Denvir, Donald A Primerano,
Donald A Primerano (11988978) +7 more
core +1 more source
HYPOMETHYLATING AGENTS IN TREATMENT OF MYELODYSPLASTIC SYNDROME [PDF]
Thelkey to the successful treatment of myelodysplastic syndrome is the careful characterization and diagnosis of the disease, which includes clinical, cytogenetic, biological and molecular investigation of individual patients.
Boyko, Olha, Olha Boyko
core +1 more source
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy [PDF]
Background: Although hypomethylating agents are currently used to treat patients with cancer, whether they can also reactivate and up-regulate oncogenes is not well elucidated.
Liu, YV +87 more
core +1 more source
Combination Therapies of Hypomethylating Agents for Elderly Patients with Acute Myeloid Leukemia [PDF]
Older patients with acute myeloid leukemia (AML) are encumbered with poor long-term outcomes due to patient and disease characteristics. Hypomethylating agents (HMAs), acting as DNA methyltransferase (DNMT) inhibitors, have been established as a new ...
Huang, Jiayu; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 210029, Nanjing, China +5 more
core +1 more source
Therapies for myelodysplastic syndromes (MDS) are chosen depending on whether a patient has lower- or higher-risk disease. Hypomethylating agents are recommended as up-front therapy for all higher-risk patients, and lower-risk patients with multiple ...
Sekeres, Mikkael A., Mikkael A. Sekeres
core +1 more source

